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Clinical Case
A 75-year-old woman presented with complaints of  vague 
abdominal pain since 3 months.
Routine laboratory investigations were unremarkable, 
except for slight anemia. Serum alfa fetoprotein (AFP) 
level, serum lactate dehydrogenase (LDH) level and serum 
carcinoembryonic antigen (CEA) levels were within normal 
limits. Liver function tests were altered, showing elevated 
alanine transferase level, alkaline transferase level and alkaline 
phosphatase level. 
The ultrasound was inconclusive due to bowel gas 
interposition.
A computed tomography (CT) scan of  the abdomen and a 
MRI were performed. Three liver lesions were identified: one 
in the segments II/III, another in the segments I/IV and 
the last one in the segment IV. These lesions did not cause 
noticeable mass effect and a few vessels were seen traversing 
the lesions without changes in caliber (fig.1E). They were 
spontaneously hypodense on the CT scan. On MRI, the 
lesions revealed high signal intensity on the T2 weighted 
and low signal intensity on the T1 weighted images. There 
was no signal loss in opposed phase images, which excluded 
intracellular fat deposition. After contrast administration, 
the lesions revealed a hypovascular nature and no contrast 
uptake on the hepatobiliary phase. These findings altogether 
suggested the diagnosis of  hepatic lymphoma. An ultrasound-
guided percutaneous lover biopsy was performed and the 
proposed diagnosis was confirmed. Further 6 month follow-
up of  the patient revealed no other focus of  lymphoma 
except the ones in the liver, which prompted the diagnosis of  
primary hepatic lymphoma.
Fig. 1 – Contrast-enhanced CT scan (A, pre-contrast; B, arterial phase; C, portal venous phase; D and E, equilibrium phase). There are two lesions in the liver 
parenchyma, one in the segments II/III and another in the segments I/IV. These lesions are spontaneously hypodense and remain hypodense in the portal 
venous and equilibrium phases. They do not cause significant mass effect and the hepatic veins are seen traversing the lesion without any change in caliber (E).
Fig. 2 – MRI (A, T2 Fat-saturated; 
B, T1 in-phase; C, T1 out-of-phase). 
The lesions are homogeneously 
hyperintense on T2 and hypointense 
on T1 weighted images. There is no 
signal loss or gain in the in-phase and 
out-of-phase images.
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Discussion
Primary hepatic lymphoma (PHL) is rare, representing <1% 
of  all non-Hodgkin’s lymphoma. It is defined as lymphoma 
that is confined to the liver and perihepatic lymph nodes, 
without evidence of  involvement of  other visceral organs, 
distant lymph nodes or bone marrow for at least 6 months 
after the onset of  hepatic disease. 
PHL is mostly diagnosed in the 4th-5th decade and shows 
a male predominance. It is commonly associated with 
viral hepatitis B and C, Epstein-Barr virus and human 
immunodeficiency virus.
It is important to make the differential diagnosis with 
secondary involvement of  the liver with lymphoma because 
the management and prognosis differ significantly.
Radiologically PHL manifests as a solitary lesion in 60% or 
as multiple lesions in 35-40% of  the cases. 
The lesions have soft tissue attenuation and are usually 
homogeneously hypodense on non-contrast-enhanced 
computed tomographic (CT) scan. Areas of  necrosis and 
hemorrhage may occasionally be seen but calcification 
Fig. 3 – MRI (A, DWI (B-800); 
B, ADC map). Note an additional 
lesion on the segment IV. All 
lesions demonstrate restricted 
diffusion with low ADC values.
Fig. 4 – Contrast-enhanced MRI using Gd-EOB-DTPA (pre-contrast; arterial phase; portal venous phase; transitional phase; 
hepatobiliary phase). All lesions remain hypointense for the entire study, including the hepatobiliary phase. 
is rare in the absence of  treatment. The majority of  the 
lesions demonstrate minimal to no enhancement on 
all post-contrast phases. On magnetic resonance (MR) 
imaging, the lesions tend to be homogeneously hypo to 
isointense on T1-weighted images and hyperintense on T2-
weighted images. Enhancement patterns on MRI are similar 
to that seen on CT. The highly cellular nature of  lymphoma 
typically results in restricted diffusion and whole-body 
diffusion-weighted imaging has been suggested to be as 
sensitive as FDG-PET/CT in staging of  lymphoma.
Although there are no pathognomonic imaging features 
diagnostic of  hepatic lymphoma, the radiologist should 
be aware of  this possibility when facing a homogeneous 
hypoenhancing intraparenchymal liver lesion, without 
significant mass effect, in a middle aged man without 
a known primary malignancy. Secondary involvement 
of  liver by lymphoma is relatively easier to diagnose on 
imaging studies due to the concomitant involvement 
of  other organs (especially the spleen) and generalized 
lymphadenopathy.
